For the quarter ending 2026-04-03, ENOV had -$3,260K decrease in cash & cash equivalents over the period. -$28,853K in free cash flow.
| Cash Flow | 2026-04-03 | 2025-12-31 | 2025-10-03 | 2025-07-04 |
|---|---|---|---|---|
| Loss on currency hedges | - | - | 0 | 0 |
| Net income (loss) | -8,450 | -520,454 | -570,913 | -92,253 |
| Depreciation and amortization | -144,011 | - | 74,380 | 142,986 |
| Impairment of assets | - | - | 0 | - |
| Goodwill and asset impairment | - | 501,309 | 548,442 | - |
| Depreciation and amortization | - | 294,378 | - | - |
| Impairment of assets | - | - | - | 0 |
| Stock-based compensation expense | 8,750 | 8,113 | 8,734 | 16,075 |
| Non-cash interest expense | 1,788 | 2,258 | 1,917 | 3,203 |
| Fair value loss on contingent acquisition shares | 0 | 0 | 0 | 1,787 |
| Unrealized loss (gain) on currency hedges | - | 0 | - | - |
| Debt extinguishment charges | - | 0 | - | - |
| Deferred income tax expense (benefit) | - | -2,226 | - | - |
| Deferred income tax benefit | -37,146 | - | 3,108 | -3,673 |
| Loss (gain) on sale of property, plant and equipment | 75 | -329 | -281 | -848 |
| Trade receivables, net | 4,347 | 10,735 | -20,807 | 20,824 |
| Inventories, net | 22,072 | -21,172 | -24,129 | 57,282 |
| Accounts payable | 26,887 | -11,482 | -12,816 | 23,161 |
| Other operating assets and liabilities | 14,174 | -22,683 | 15,493 | -32,145 |
| Net cash provided by (used in) operating activities | 23,951 | 88,544 | 82,576 | 46,173 |
| Cash received upon settlement of derivatives | - | - | 0 | 1,601 |
| Purchases of property, plant and equipment and intangibles | 52,804 | 56,254 | 53,491 | 87,631 |
| Proceeds from sale of property, plant and equipment | - | 0 | - | - |
| Payments for acquisitions, net of cash received, and investments | 291 | 0 | 2,569 | 24,290 |
| Proceeds from sale of business, net | - | 43,263 | - | - |
| Cash received upon settlement of derivatives | 0 | -1,601 | - | - |
| Net cash used in investing activities | -53,095 | -12,991 | -56,060 | -110,320 |
| Proceeds from borrowings on term credit facility | - | 335,000 | 0 | 0 |
| Repayments of borrowings under term credit facility | 8,750 | 8,750 | 5,000 | 10,000 |
| Proceeds from borrowings on revolving credit facilities and other | 72,000 | 32,000 | 50,000 | 127,000 |
| Repayments of borrowings on revolving credit facilities and other | 35,516 | 420,313 | 81,867 | 54,995 |
| Proceeds from borrowings on senior unsecured convertible notes | - | 0 | - | - |
| Payment of debt issuance costs | - | 6,674 | 0 | 0 |
| Proceeds from issuance of common stock, net | - | 1,318 | - | - |
| Payment of capped call transactions | - | 0 | - | - |
| Payments of tax withholding for stock-based awards | 943 | 0 | 57 | 3,447 |
| Proceeds from issuance of common stock, net | -690 | - | 189 | 1,129 |
| Deferred consideration payments and other | -1,396 | -4,178 | -172 | -2,265 |
| Net cash provided by financing activities | 26,023 | -72,915 | -36,907 | 57,422 |
| Effect of foreign exchange rates on cash and cash equivalents | -139 | 134 | -66 | 2,632 |
| Decrease in cash and cash equivalents | -3,260 | 2,772 | -10,457 | -4,093 |
| Cash and cash equivalents, beginning of period | 36,389 | 33,617 | 48,167 | - |
| Cash and cash equivalents, end of period | 33,129 | 36,389 | 33,617 | - |